StratifAI

Raised $14.7M in a Series A round, announced 30 September 2025.

Latest round Series ACountry GermanySector AI

Round

Funds clinical validation of its Polaris Breast platform and EU and US approvals.

Amount: $14.7M
Stage: Series A
Announced: 30 September 2025
Lead: Picus Capital
Other investors: Alven, Heliad, Debiopharm Group, Arve Capital, Christoph Haarburger, Rubin Ritter, Lars Langusch, Jens Begemann
Use of funds: Funds clinical validation of its Polaris Breast platform and EU and US approvals.
Checked: Amount and date matched across 2 press sources
Sources: StratifAI raises €13M deutsche-startups.de
StratifAI raises €13M funding.tech.eu

AI biomarker platform for precision oncology

How much has StratifAI raised?

StratifAI raised $14.7M in a Series A round, announced on 30 September 2025.

Who invested in StratifAI?

Picus Capital led. Investors include Picus Capital, Alven, Heliad, Debiopharm Group, Arve Capital and Christoph Haarburger.